Global Capecitabine Market Research Report 2012-2024

June 2019 | 69 pages | ID: G82D826E7A7EN
HeyReport

Abstracts

SUMMARY

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

• 500 mg
• 150 mg

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

• Teva
• Roche
• Mylan
• Hikma
• Hengrui Medicine
• Cipla
• Reliance Group
• Hetero

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

• Breast Cancer
• Colorectal cancer
• Stomach Cancer

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 500 mg
    1.2.1.2 150 mg
  1.2.2 by Application
    1.2.2.1 Breast Cancer
    1.2.2.2 Colorectal cancer
    1.2.2.3 Stomach Cancer
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 500 mg Market, 2013-2018
  4.1.2 150 mg Market, 2013-2018
4.2 Market Forecast
  4.2.1 500 mg Market Forecast, 2019-2024
  4.2.2 150 mg Market Forecast, 2019-2024

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Breast Cancer Market, 2013-2018
  5.1.2 Colorectal cancer Market, 2013-2018
  5.1.3 Stomach Cancer Market, 2013-2018
5.2 Market Forecast
  5.2.1 Breast Cancer Market Forecast, 2019-2024
  5.2.2 Colorectal cancer Market Forecast, 2019-2024
  5.2.3 Stomach Cancer Market Forecast, 2019-2024

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2012-2018
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2012-2018
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2012-2018
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2012-2018
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2012-2018
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2019-2024
  6.2.2 North America Market Forecast, 2019-2024
  6.2.3 Europe Market Forecast, 2019-2024
  6.2.4 South America Market Forecast, 2019-2024
  6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Teva
8.2 Roche
8.3 Mylan
8.4 Hikma
8.5 Hengrui Medicine
8.6 Cipla
8.7 Reliance Group
8.8 Hetero

9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Specifications of Capecitabine
Table Products Segment of Capecitabine
Table 500 mg Overview
Table 150 mg Overview
Table Global Capecitabine Market by Type, 2011-2022 (USD Million)
Table Application Segment of Capecitabine
Table Breast Cancer Overview
Table Colorectal cancer Overview
Table Stomach Cancer Overview
Table Global Capecitabine Market by Application, 2011-2022 (USD Million)
Table Global Capecitabine Market by Region, 2011-2022 (USD Million)
Table Cost of Capecitabine
Table Market Dynamics
Table Policy of Capecitabine
Table GDP of Major Countries
Table 500 mg CAGR by Revenue and Volume, 2012-2018
Table 150 mg CAGR by Revenue and Volume, 2012-2018
Table 500 mg CAGR by Revenue and Volume, 2012-2024
Table 150 mg CAGR by Revenue and Volume, 2012-2024
Table Breast Cancer CAGR by Revenue and Volume, 2012-2018
Table Colorectal cancer CAGR by Revenue and Volume, 2012-2018
Table Stomach Cancer CAGR by Revenue and Volume, 2012-2018
Table Global Capecitabine Market by Vendors, 2012-2018 (USD Million)
Table Global Capecitabine Market by Vendors, 2012-2018 (in Volume)
Table Global Capecitabine Market Share by Vendors, 2012-2018 (USD Million)
Table Global Capecitabine Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Profile List
Table Microecological Modulator Operating Data of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hengrui Medicine Profile List
Table Microecological Modulator Operating Data of Hengrui Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Reliance Group Profile List
Table Microecological Modulator Operating Data of Reliance Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hetero Profile List
Table Microecological Modulator Operating Data of Hetero (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Capecitabine Picture
Figure Industry Chain Structure of Capecitabine
Figure SWOT of Capecitabine
Figure 500 mg Market Size and Growth, 2012-2018 (USD Million)
Figure 500 mg Market Size and Growth, 2012-2018 (in Volume)
Figure 150 mg Market Size and Growth, 2012-2018 (USD Million)
Figure 150 mg Market Size and Growth, 2012-2018 (in Volume)
Figure 500 mg Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 500 mg Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure 150 mg Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure 150 mg Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Breast Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Colorectal cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Stomach Cancer Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Capecitabine Market Concentration by Region
Figure Marketing Channels Overview